Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,126 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07147049RecruitingPhase 2
Testing a new painkiller for moderate to severe pain after surgery
This trial tests a new tablet called HL-1186 for people with moderate to severe pain after certain surgeries. It aims to see if the drug is safe and works well for pain control.
Chengdu, SichuanAges 18–75 - NCT07311369RecruitingPhase 2
Testing a new pain tablet after abdominal surgery
This trial tests a new pain tablet (HL-1186) for people having abdominal surgery. It aims to see if the tablet is safe and works well to manage pain after the operation.
Changsha, HunanAges 18–75 - NCT07107633RecruitingPhase 2
Imaging test for cancer spread in the abdomen
This trial tests a special imaging injection to see if it can better detect cancer that has spread to the lining of the abdomen in people with stomach or bowel cancer. If you are scheduled for surgery to remove or explore the cancer, this scan might help your doctor plan the best treatment.
ShanghaiAges 18 years+ - NCT06713603Recruiting
Digital smoking cessation with motivational counseling
This study tests a digital program that uses personalized counseling over video or phone to help people stop smoking. It is for adults who smoke daily, have a primary care doctor, and can use a smartphone or computer.
San Francisco, CaliforniaAges 18 years+ - NCT07131215Recruiting
Smart technology for health in early menopause
This trial tests whether a smartphone-based program can help monitor and improve the physical and mental health of women who have recently gone through menopause. It aims to see if technology can support healthy lifestyle changes during this transition.
TainanAges 40–65 - NCT07488546Enrolling by invitationPhase 1/Phase 2
HCL001 cell therapy for advanced liver cirrhosis
This trial tests a new cell injection called HCL001 for people with decompensated cirrhosis (advanced liver scarring causing complications). The goal is to see if it's safe and helps improve liver function. It may be an option if you've tried standard treatments and meet specific health criteria.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05653453RecruitingPhase 3
Tumor treatment device plus chemo for locally advanced pancreatic cancer
This trial tests whether a home-wearable tumor-treating device (Tumor Treating Fields) combined with gemcitabine and albumin-bound paclitaxel works better as first treatment for locally advanced pancreatic cancer. It may help by targeting cancer cells while also using standard chemotherapy.
Harbin, HeilongjiangAges 18–75 - NCT07117435RecruitingPhase 1
Targeted chemo into liver for colorectal cancer spread
This trial is testing a new way to give the chemotherapy drug paclitaxel directly into the liver (through a tiny tube) along with standard systemic treatment for people whose colorectal cancer has spread only to the liver and cannot be surgically removed. The goal is to see if this targeted approach works better than standard treatment alone.
Lishui, ZhejiangAges 18–75 - NCT05598983Recruiting
Remote monitoring to catch COPD flare-ups early
This study tests a non-contact, at-a-distance monitoring system to help detect COPD flare-ups early. If you’ve had flare-ups before, it may help track changes sooner and support better care decisions.
LondonAges 18 years+ - NCT07034105Recruiting
Walking patterns in healthy people and stroke survivors
This study compares how people walk on different surfaces and with body weight support. It aims to understand walking differences between healthy individuals and stroke survivors, which could help design better rehab programs.
DhakaAges 18–75 - NCT05131750Recruiting
Study how RIR affects outcomes after heart stent procedures
This trial looks at a factor called RIR and whether it changes health outcomes for people with coronary heart disease who get a PCI (a heart stent procedure) while in the hospital. It may help doctors understand who benefits and how to improve care after stenting.
Wuhan, HubeiAges 18–80 - NCT07533071Recruiting
Study of Timing in Getting Hearing Aid Help
This research examines how delays in getting hearing aids or other listening devices affect people's everyday communication and quality of life. Understanding this may help doctors better support people with hearing loss.
Chicago, IllinoisAges 18 years+ - NCT06992271Recruiting
Comparing two exercise styles on muscle recovery
This study tests two different types of arm exercises to see how they affect muscle soreness and damage. If you've lifted weights before but aren't currently doing chest presses every week, this may help you understand how your body recovers after different workouts.
Old Westbury, New YorkAges 18–35 - NCT05733377Recruiting
Non-invasive scans to study back curve during pregnancy
This trial uses a non-invasive imaging scan to measure a common back curvature called lordosis during pregnancy. Researchers will look at how these measurements relate to birth outcomes in low-risk pregnancies.
Alcalá de Henares, MadridAges 20–40 - NCT07355972RecruitingEarly Phase 1
CT1195E cell therapy for progressive scleroderma
This trial tests a new cell therapy called CT1195E for people with refractory or progressive systemic sclerosis (scleroderma) that also affects the lungs. It aims to see if the treatment is safe and can help slow or stop the disease.
Wuhan, HubeiAges 18–60 - NCT07145151RecruitingPhase 2
Studying UBT251 for MASH liver disease
This trial tests a new medication called UBT251 for people with MASH, a type of liver disease linked to weight and metabolism. It aims to see if the medicine can reduce liver damage and scarring.
Beijing, Beijing MunicipalityAges 18–75 - NCT07142304Recruiting
A study of compression gloves and boots to prevent chemo nerve damage
This trial is testing a wearable device (gloves and boots) that applies gentle compression to your hands and feet during chemotherapy. It aims to prevent or reduce nerve damage (numbness, tingling, pain) that some chemotherapy drugs can cause.
Poway, CaliforniaAges 18 years+ - NCT06422845Recruiting
Drug-coated balloon for dialysis fistula narrowing
This trial tests a special balloon that releases medication to help keep your dialysis fistula (the blood vessel used for treatment) open longer if it has narrowed. It may be a good option if you have a blockage in the vein side of your fistula that causes problems during dialysis.
Hefei, AnhuiAges 18–80 - NCT06990529RecruitingPhase 2
Long-term safety and effectiveness of leniolisib for immune problems
This study tests the long-term safety and effectiveness of the drug leniolisib for people with certain immune system disorders. It is for people who have already been in a previous study of this drug and may benefit from continuing treatment.
Bethesda, MarylandAges 12–75 - NCT06313086RecruitingPhase 3
New drug vs. T-DM1 for HER2-positive advanced breast cancer
This trial tests a new antibody-drug conjugate (DP303c) against an existing one, T-DM1, in people with HER2-positive advanced breast cancer who have already been treated with trastuzumab and a taxane. The goal is to see if the new drug works better or has fewer side effects.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06725953Recruiting
Remote exercise program for cancer survivors with or without diabetes
This study tests a 12-week home-based physical activity program to see if it helps cancer survivors who had chemotherapy and now have memory or thinking problems. It includes both survivors with type 2 diabetes and those without.
Oklahoma City, OklahomaAges 18 years+ - NCT07695168Recruiting
Digital course and rehab for knee osteoarthritis
This study tests whether a digital program with special sensors and a digital twin can help reduce knee pain and improve mobility in older adults with knee osteoarthritis. It also includes healthy adults for comparison.
TaipeiAges 20–80 - NCT07672561RecruitingPhase 3
Testing a new pill for moderate to severe plaque psoriasis
This study tests an experimental pill called WD-890 to see if it can help people with moderate to severe plaque psoriasis. The pill is compared to a placebo (a pill with no medicine) to check if it is safe and works well.
Nanjing, JiangsuAges 18–75 - NCT07458958Recruiting
Fall prevention program for community seniors
This trial tests a fall prevention program for older adults living in the community. It aims to help you learn how to reduce your risk of falling and stay safe on your feet.
Guangzhou, GuangdongAges 60–80
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,126 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.